Uranium
Compare Stocks
2 / 10Stock Comparison
CCJ vs EU
Revenue, margins, valuation, and 5-year total return — side by side.
Uranium
CCJ vs EU — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Uranium | Uranium |
| Market Cap | $51.67B | $348M |
| Revenue (TTM) | $3.48B | $44M |
| Net Income (TTM) | $589M | $-67M |
| Gross Margin | 29.4% | 3.2% |
| Operating Margin | 17.5% | -203.8% |
| Forward P/E | 74.0x | — |
| Total Debt | $1.02B | $20M |
| Cash & Equiv. | $1.11B | $40M |
CCJ vs EU — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cameco Corporation (CCJ) | 100 | 1091.6 | +991.6% |
| enCore Energy Corp. (EU) | 100 | 328.1 | +228.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCJ vs EU
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCJ carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 1.72, yield 0.1%
- Lower volatility, beta 1.72, Low D/E 14.8%, current ratio 2.47x
- Beta 1.72, yield 0.1%, current ratio 2.47x
EU is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 163.4%, EPS growth -88.9%
- 30.2% 10Y total return vs CCJ's 9.3%
- 163.4% revenue growth vs CCJ's 10.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 163.4% revenue growth vs CCJ's 10.9% | |
| Quality / Margins | 16.9% margin vs EU's -152.1% | |
| Stability / Safety | Beta 1.72 vs EU's 2.04 | |
| Dividends | 0.1% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +138.9% vs EU's +16.9% | |
| Efficiency (ROA) | 6.0% ROA vs EU's -17.2%, ROIC 6.3% vs -18.9% |
CCJ vs EU — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CCJ leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CCJ is the larger business by revenue, generating $3.5B annually — 78.9x EU's $44M. CCJ is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to EU's -152.1%. On growth, CCJ holds the edge at +1.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.5B | $44M |
| EBITDAEarnings before interest/tax | $912M | -$81M |
| Net IncomeAfter-tax profit | $589M | -$67M |
| Free Cash FlowCash after capex | $1.1B | -$60M |
| Gross MarginGross profit ÷ Revenue | +29.4% | +3.2% |
| Operating MarginEBIT ÷ Revenue | +17.5% | -2.0% |
| Net MarginNet income ÷ Revenue | +16.9% | -152.1% |
| FCF MarginFCF ÷ Revenue | +30.3% | -135.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.4% | -4.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +45.2% | +61.1% |
Valuation Metrics
EU leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $51.7B | $348M |
| Enterprise ValueMkt cap + debt − cash | $51.6B | $329M |
| Trailing P/EPrice ÷ TTM EPS | 119.93x | -5.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 74.01x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 79.53x | — |
| Price / SalesMarket cap ÷ Revenue | 20.26x | 5.97x |
| Price / BookPrice ÷ Book value/share | 10.22x | 1.07x |
| Price / FCFMarket cap ÷ FCF | 68.99x | — |
Profitability & Efficiency
CCJ leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CCJ delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-23 for EU. EU carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCJ's 0.15x. On the Piotroski fundamental quality scale (0–9), CCJ scores 8/9 vs EU's 3/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.8% | -22.5% |
| ROA (TTM)Return on assets | +6.0% | -17.2% |
| ROICReturn on invested capital | +6.3% | -18.9% |
| ROCEReturn on capital employed | +6.5% | -21.1% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 3 |
| Debt / EquityFinancial leverage | 0.15x | 0.06x |
| Net DebtTotal debt minus cash | -$92M | -$19M |
| Cash & Equiv.Liquid assets | $1.1B | $40M |
| Total DebtShort + long-term debt | $1.0B | $20M |
| Interest CoverageEBIT ÷ Interest expense | 10.04x | -39.33x |
Total Returns (Dividends Reinvested)
CCJ leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCJ five years ago would be worth $59,356 today (with dividends reinvested), compared to $5,027 for EU. Over the past 12 months, CCJ leads with a +138.9% total return vs EU's +16.9%. The 3-year compound annual growth rate (CAGR) favors CCJ at 63.0% vs EU's -6.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +20.4% | -31.3% |
| 1-Year ReturnPast 12 months | +138.9% | +16.9% |
| 3-Year ReturnCumulative with dividends | +333.3% | -18.7% |
| 5-Year ReturnCumulative with dividends | +493.6% | -49.7% |
| 10-Year ReturnCumulative with dividends | +934.7% | +3016.7% |
| CAGR (3Y)Annualised 3-year return | +63.0% | -6.7% |
Risk & Volatility
CCJ leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CCJ is the less volatile stock with a 1.72 beta — it tends to amplify market swings less than EU's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CCJ currently trades 87.7% from its 52-week high vs EU's 44.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.72x | 2.04x |
| 52-Week HighHighest price in past year | $135.24 | $4.18 |
| 52-Week LowLowest price in past year | $47.87 | $1.54 |
| % of 52W HighCurrent price vs 52-week peak | +87.7% | +44.7% |
| RSI (14)Momentum oscillator 0–100 | 56.1 | 49.2 |
| Avg Volume (50D)Average daily shares traded | 3.2M | 2.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CCJ as "Buy" and EU as "Buy". Consensus price targets imply 127.3% upside for EU (target: $4) vs 6.1% for CCJ (target: $126). CCJ is the only dividend payer here at 0.15% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $125.91 | $4.25 |
| # AnalystsCovering analysts | 19 | 2 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | — |
| Dividend StreakConsecutive years of raises | 2 | — |
| Dividend / ShareAnnual DPS | $0.24 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
CCJ leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EU leads in 1 (Valuation Metrics).
CCJ vs EU: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CCJ or EU a better buy right now?
For growth investors, enCore Energy Corp.
(EU) is the stronger pick with 163. 4% revenue growth year-over-year, versus 10. 9% for Cameco Corporation (CCJ). Cameco Corporation (CCJ) offers the better valuation at 119. 9x trailing P/E (74. 0x forward), making it the more compelling value choice. Analysts rate Cameco Corporation (CCJ) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CCJ or EU?
Over the past 5 years, Cameco Corporation (CCJ) delivered a total return of +493.
6%, compared to -49. 7% for enCore Energy Corp. (EU). Over 10 years, the gap is even starker: EU returned +30. 2% versus CCJ's +934. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CCJ or EU?
By beta (market sensitivity over 5 years), Cameco Corporation (CCJ) is the lower-risk stock at 1.
72β versus enCore Energy Corp. 's 2. 04β — meaning EU is approximately 19% more volatile than CCJ relative to the S&P 500. On balance sheet safety, enCore Energy Corp. (EU) carries a lower debt/equity ratio of 6% versus 15% for Cameco Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — CCJ or EU?
By revenue growth (latest reported year), enCore Energy Corp.
(EU) is pulling ahead at 163. 4% versus 10. 9% for Cameco Corporation (CCJ). On earnings-per-share growth, the picture is similar: Cameco Corporation grew EPS 246. 2% year-over-year, compared to -88. 9% for enCore Energy Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CCJ or EU?
Cameco Corporation (CCJ) is the more profitable company, earning 16.
9% net margin versus -105. 2% for enCore Energy Corp. — meaning it keeps 16. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCJ leads at 16. 7% versus -123. 7% for EU. At the gross margin level — before operating expenses — CCJ leads at 26. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CCJ or EU more undervalued right now?
Analyst consensus price targets imply the most upside for EU: 127.
3% to $4. 25.
07Which pays a better dividend — CCJ or EU?
In this comparison, CCJ (0.
1% yield) pays a dividend. EU does not pay a meaningful dividend and should not be held primarily for income.
08Is CCJ or EU better for a retirement portfolio?
For long-horizon retirement investors, Cameco Corporation (CCJ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+934.
7% 10Y return). enCore Energy Corp. (EU) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CCJ: +934. 7%, EU: +30. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CCJ and EU?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CCJ is a mid-cap quality compounder stock; EU is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.